HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Uses comparative genomics and model system genetics to identify novel genes or proteins that represent potential product targets or drugs to treat disease or prevent disease initiation or progression. The company's most advanced pharmaceutical program focuses on small molecules in cancer.
| Market Cap | 6.296 Billion | Shares Outstanding | 295.85 Million | Avg Volume | 5.955 Million |
| 1-Yr BETA vs S&P TR | Current Ratio | 4.21 | Quick Ratio | 4.15 |
| Q1 2019 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade EXEL now: | |
|
| Filers who had this stock in their top 10: | 2 | 0 (0.0%) |
| 13F Filers holding this stock: | 363 | 38 (3.87%) |
| Aggregate 13F shares on 03/31/2019: | 235.754 Million | 35.967 Million |
| Aggregate 13F shares on 12/31/2018: | 228.866 Million | 35.64 Million |
| Percent change: | 3.01% | 0.92% |
| Funds creating new positions: | 84 | 5 |
| Funds Adding to an existing position: | 151 | 17 |
| Funds closing out their position: | 47 | 14 |
| Funds reducing their position: | 80 | 12 |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Please sign in first
none
277.9 Thousand total shares from 11 transactions
139.2 Thousand total shares from 5 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
LAMB PETER EVP, SCIENTIFIC STRATEGY & CSO |
|
134,302 | 2019-06-13 | 3 |
|
0 | 2019-06-12 | 2 | |
|
KARBE FRANK PRINCIPAL FIN'L & ACCOUNTING |
|
8,000 | 2019-06-11 | 0 |
|
HALEY PATRICK J. SR. VICE PRESIDENT, COMMERCIAL |
|
122,640 | 2019-06-10 | 15 |
|
0 | 2019-06-06 | 0 | |
|
1,231,626 | 2019-06-03 | 14 | |
|
5,191 | 2019-06-01 | 3 | |
|
MORRISSEY MICHAEL PRESIDENT AND CEO |
|
316,317 | 2019-05-29 | 19 |
|
0 | 2019-05-23 | 3 | |
|
0 | 2019-05-23 | 3 | |
|
0 | 2019-05-23 | 2 | |
|
144,167 | 2019-05-23 | 3 | |
|
1,052,568 | 2019-05-23 | 2 | |
|
112,792 | 2019-05-23 | 2 | |
|
0 | 2019-05-23 | 1 | |
|
32,374 | 2019-05-23 | 1 | |
|
0 | 2019-05-08 | 4 | |
|
SCHWAB GISELA PRES, PROD DEV & MED AFF & CMO |
|
331,251 | 2019-04-03 | 12 |
|
HESSEKIEL JEFFREY EVP AND GENERAL COUNSEL |
|
234,819 | 2019-04-01 | 4 |
|
0 | 2018-06-06 | 0 | |
|
47,961 | 2017-10-13 | 0 | |
|
BURKE DEBORAH SVP & CHIEF FINANCIAL OFFICER |
|
19,990 | 2014-11-15 | 0 |
|
SIMONTON PAMELA A EVP, EXELIXIS |
|
28,091 | 2014-02-15 | 0 |
|
RIVERA LUPE M EVP, OPERATIONS |
|
22,051 | 2011-08-15 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-06-13 | M | 27,596 | $5.56 | a | 144,793 | 134,302.00 | direct | ||
| 2019-06-13 | M | 27,596 | d | 95,404 | 134,302.00 | direct | |||
| 2019-06-13 | S | 27,596 | $20.03 | d | 117,197 | 134,302.00 | direct | yes | |
| 2019-06-10 | S | 1,000 | $20.23 | d | 88,453 | 122,640.00 | direct | yes | |
| 2019-06-04 | S | 15,000 | $20.00 | d | 1,208,031 | 1,231,626.00 | direct | yes | |
| 2019-06-03 | S | 25,000 | $19.61 | d | 1,223,031 | 1,231,626.00 | direct | yes | |
| 2019-05-29 | M | 14,591 | $7.18 | a | 104,591 | 316,317.00 | direct | ||
| 2019-05-29 | M | 14,591 | a | 285,409 | 316,317.00 | direct | |||
| 2019-05-23 | A | 10,317 | a | 130,526 | 130,526.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-23 | A | 10,317 | a | 32,374 | 32,374.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-23 | A | 20,634 | a | 20,634 | 144,167.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-23 | A | 20,634 | a | 20,634 | 1,052,568.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-23 | A | 20,634 | a | 20,634 | 112,792.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-23 | A | 10,317 | a | 144,167 | 144,167.00 | direct | |||
| 2019-05-23 | A | 20,634 | a | 20,634 | 130,526.00 | direct | |||
| 2019-05-23 | A | 10,317 | a | 1,052,568 | 1,052,568.00 | direct | |||
| 2019-05-23 | A | 20,634 | a | 20,634 | 32,374.00 | direct | |||
| 2019-05-23 | A | 10,317 | a | 112,792 | 112,792.00 | direct | |||
| 2019-05-23 | A | 42,641 | a | 42,641 | 0.00 | direct | |||
| 2019-05-21 | M | 15,000 | $4.57 | a | 1,248,031 | 1,271,626.00 | direct | ||
| 2019-05-21 | M | 15,000 | d | 0 | 1,271,626.00 | direct | |||
| 2019-05-10 | S | 1,000 | $19.58 | d | 89,453 | 123,640.00 | direct | yes | |
| 2019-05-08 | M | 42,000 | d | 0 | 301,726.00 | direct | |||
| 2019-05-08 | S | 42,000 | $20.15 | d | 90,000 | 301,726.00 | direct | yes | |
| 2019-05-08 | S | 50,000 | $20.36 | d | 368,273 | 368,273.00 | direct | ||
| 2019-05-08 | M | 42,000 | $5.56 | a | 132,000 | 301,726.00 | direct | ||
| 2019-05-03 | S | 36,261 | $20.70 | d | 112,362 | 115,085.00 | direct | ||
| 2019-05-02 | S | 15,000 | $20.00 | d | 1,233,031 | 1,256,626.00 | direct | yes | |
| 2019-05-01 | S | 25,000 | $19.75 | d | 1,248,031 | 1,256,626.00 | direct | yes | |
| 2019-04-24 | M | 40,000 | $5.56 | a | 130,000 | 301,695.00 | direct | ||
| 2019-04-24 | M | 40,000 | d | 42,000 | 301,695.00 | direct | |||
| 2019-04-24 | S | 40,000 | $20.75 | d | 90,000 | 301,695.00 | direct | yes |
